SCHEMBL7491988

SCHEMBL7491988

COc1cccc2c1CCC2N(Cc1nc(-c2ccccc2)c(-c2ccccc2)o1)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 12/20 0.41
RXRA P19793 3/20 0.39
RXRB P28702 1/20 0.37
PTGIR P43119 1/20 0.36
NR4A1 P22736 2/20 0.36
NR4A3 Q92570 2/20 0.36
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
HTR1A P08908 1/20 0.35
DRD2 P14416 1/20 0.35
TSHR P16473 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
HTR5A P47898 1/20 0.35
KMT2A Q03164 1/20 0.35
TRPA1 O75762 1/20 0.35
TRPV1 Q8NER1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7498928 0.88 PTGIR (0.45) NR4A2RXRARXRBPTGIRNR4A1
SCHEMBL7484361 0.88 NR4A2 (0.44) NR4A2RXRARXRBPTGIRNR4A1
SCHEMBL7493134 0.86 NR4A2 (0.41) NR4A2RXRARXRBPTGIRNR4A1
SCHEMBL7490736 0.84 NR4A2 (0.41) NR4A2RXRARXRBPTGIRNR4A1
SCHEMBL7491313 0.84 PTGIR (0.43) NR4A2RXRARXRBPTGIRNR4A1
SCHEMBL7493526 0.84 NR4A2 (0.45) NR4A2RXRARXRBPTGIRNR4A1
SCHEMBL7481949 0.83 NR4A2 (0.46) NR4A2RXRARXRBPTGIRNR4A1
SCHEMBL7487529 0.82 NR4A2 (0.43) NR4A2RXRAPTGIRNR4A1NR4A3
SCHEMBL7481647 0.77 NR4A2 (0.42) NR4A2RXRAMEN1CYP1A2HTR1A
SCHEMBL7493599 0.76 NR4A2 (0.51) NR4A2RXRARXRBNR4A1NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0842161-B1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2002-09-18 EP disclosed
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
EP-0842161-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-20 EP disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed